Traders Buy Large Volume of Put Options on ARK Genomic Revolution ETF (BATS:ARKG)

ARK Genomic Revolution ETF (BATS:ARKG) saw unusually large options trading activity on Wednesday. Stock investors acquired 79,250 put options on the stock. This is an increase of approximately 700% compared to the average volume of 9,906 put options.

Institutional Investors Weigh In On ARK Genomic Revolution ETF

Hedge funds and other institutional investors have recently made changes to their positions in the company. National Bank of Canada FI raised its stake in shares of ARK Genomic Revolution ETF by 28.4% in the third quarter. National Bank of Canada FI now owns 4,155 shares of the company’s stock valued at $106,000 after acquiring an additional 920 shares during the period. IHT Wealth Management LLC purchased a new stake in shares of ARK Genomic Revolution ETF in the third quarter valued at $203,000. Sanctuary Advisors LLC purchased a new stake in shares of ARK Genomic Revolution ETF in the second quarter valued at $222,000. Hilltop Holdings Inc. purchased a new position in ARK Genomic Revolution ETF in the 3rd quarter worth about $237,000. Finally, Choreo LLC purchased a new position in ARK Genomic Revolution ETF in the 2nd quarter worth about $314,000.

ARK Genomic Revolution ETF Trading Down 0.1 %

Shares of ARK Genomic Revolution ETF stock opened at $25.57 on Friday. The business has a fifty day simple moving average of $24.82 and a two-hundred day simple moving average of $25.00.

ARK Genomic Revolution ETF Company Profile

The ARK Genomic Revolution ETF (ARKG) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund that targets companies involved in the genomics industry. ARKG was launched on Oct 31, 2014 and is managed by ARK.